Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

Merck Boosts Revenue Guidance After Strong Q2

Guavy AI Editorial Team
Instruments
MRK
Share

Merck & Co Inc (MRK) reported strong Q2 2026 revenue of $16.6 billion, a 5% increase from last year.

The growth was driven by robust oncology and animal health performance, with KEYTRUDA family sales increasing 4% to $8.4 billion.

KEYTRUDA QLEX sales reached $463 million, with adoption increasing since the permanent J-code was established in April.

The company raised its full-year 2026 revenue guidance to $66.3-$67.3 billion, reflecting confidence in continued growth.

More on Stocks

Stocks just now

Stock Market Reaches New Heights as AI-Linked Companies Boost Earnings

Stocks just now

Dow Rockets Over 700 Points as Pfizer Exceeds Earnings Expectations

Stocks just now

Apple Surpasses $10 Billion in Sales in India for First Time

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Real-time market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy